The product innovations MASTERPULS® ultra+ and MAGNETOLITH® ultra+ cause a stir at Rééduca and REHACARE International 2024
STORZ MEDICAL presented two new devices at the trade fairs Rééduca in Paris and REHACARE International in Düsseldorf in September 2024: the new radial ESWT entry-level device, MASTERPULS® ultra+, and the EMTT innovation, MAGNETOLITH® ultra+. These technologies, based on Extracorporeal Shock Wave Therapy (ESWT) and Extracorporeal Magnetotransduction Therapy (EMTT), expand the STORZ MEDICAL product portfolio in orthopaedics and rehabilitation medicine respectively.
New features stir up excitement
The response from visitors at both events was exceptional. The new MASTERPULS® ultra+ impressed not only with its high performance and wide range of indications, but also with its simple operating concept, reduced to essential functions. The integrated touchscreen makes the device particularly user-friendly.
The MAGNETOLITH® ultra+ captivated the trade audience, particularly with its extended intensity level and therefore optimised performance. The magnetic pulses generated have been modulated in such a way that they achieve a longer oscillation period without changing the frequency or the maximum amplitude. The perception of therapy and nerve activation is intensified.
A look back over two thoroughly successful trade fair appearances
Participation in both trade shows was a complete success. Rééduca in Paris (19 - 21 September) is one of the most significant events in France for rehabilitation and physiotherapy professionals. Over 100 exhibitors presented their latest innovations. REHACARE International, which took place the following week (25 - 28 September) in Düsseldorf, is one of the leading events for rehabilitation, prevention, integration and care, with over 850 exhibitors from 40 countries.
At both events, we had the opportunity to make valuable new connections, engage with an international professional audience, and present our latest innovations MASTERPULS® ultra+ and MAGNETOLITH® ultra+. The features of both models met with broad recognition and were acclaimed as advancements in non-invasive pain therapy. We are now eagerly looking ahead and look forward to presenting our latest developments to you live at the upcoming events.
